Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Organigram Global Inc.NASDAQ: OGI

Retained Earnings · Q2 FY2026 · quarter ended Mar 2026

Retained earnings remains negative

Q2 FY2026 retained earnings was -CA$591.2M, compared with -CA$564.47M a year earlier.

Context

  • Retained earnings amounted to 113.1% of total assets at the end of Q2 FY2026, up 8.2 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -4.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$591.2M-0.5% QoQ
Last fiscal yearSep 2025
-CA$608.73M-4.2% YoY
Year agoMar 2025
-CA$564.47M-4.7% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.7%——
1 year-4.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

CAD · from the balance sheet

Latest · FY2025
(608.73M) CAD
Year-over-year change
-4.2%

Retained Earnings vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -4.7% is the 4th highest of 9, against a peer median of -13.6%.
  • Retained earnings amounts to 113.1% of total assets for OGI, versus a peer median of 142.3%.
OGI Competitors
Retained Earnings for OGI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ELMDElectromed, Inc.Mar 2026$25.14M USD+11.4%+10.3%42.3%
INFUInfuSystem Holdings, Inc.Mar 2026-$60.54M USD+0.1%—61.4%
DERMJourney Medical CorporationMar 2026-$100.69M USD-10.5%—110.0%
LFCRLifecore Biomedical, Inc.Dec 2025-$223.2M USD——96.1%
HSDTSolana CompanyMar 2026-$312.39M USD-78.0%—155.6%
IVAInventiva S.A.Dec 2025-€354.14M EUR-92.2%—142.3%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026-$383.27M USD-16.6%—380.8%
OGIOrganigram Global Inc.Mar 2026-CA$591.2M CAD-4.7%—113.1%
RNACCartesian Therapeutics, Inc.Mar 2026-$861.56M USD-21.4%—298.7%
ACBAurora Cannabis Inc.Mar 2026-CA$6.46B CAD-2.0%—1071.7%
Peer median (excluding OGI) —-13.6%+10.3%142.3%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents55.37M68.52M33.86M106.75M28.2M
Short-term Investments128.48M30.4M0821K826K
Net Receivables21M46.37M27.46M37.15M64.86M
Inventory48.82M68.28M80.95M82.52M123.95M
Other Current Assets5.51M2.21M13.7M25.86M55.39M
Total Current Assets260.62M221.62M155.98M262.22M284.9M
Property, Plant & Equipment (Net)235.94M259.82M99.05M96.23M122.98M
Goodwill14.32M41.98M0052.52M
Intangible Assets2.73M14.26M10.62M8.09M48.51M
Long-term Investments6.11M7.07M13.72M40.73M49.55M
Tax Assets3.2M0000
Other Non-current Assets31.11M32.36M19.09M591K3.75M
Total Non-current Assets293.4M355.48M142.48M145.64M277.31M
Total Assets554.02M577.11M298.46M407.86M562.21M
Account Payables18.95M40.86M14.73M47.1M89.25M
Short-term Debt80K80K76K60K25K
Tax Payables01.42M94K00
Deferred Revenue02.44M000
Other Current Liabilities6.25M12M2.35M5.14M35.91M
Total Current Liabilities26.27M55.29M22.43M53.32M126.16M
Long-term Debt230K155K3.63M25K0
Deferred Tax Liabilities03.62M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.07M7.79M771K45.18M79.17M
Total Non-current Liabilities47.95M13.76M4.4M48.55M86.92M
Total Liabilities74.21M69.05M26.83M101.87M213.08M
Common Stock730.8M769.73M776.91M852.89M919.91M
Retained Earnings(275.64M)(289.93M)(538.53M)(583.97M)(608.73M)
Accumulated OCI24.65M28.26M33.25M37.07M37.95M
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.81M508.06M271.62M305.99M349.13M
Total Debt5.95M3.36M3.71M4.46M8.75M
Net Debt(49.42M)(65.16M)(30.16M)(102.29M)(19.45M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.